Opinion

Video

Pharmacist-Led Strategies for Adverse Event Management in mCRC

Experts discuss how pharmacists contribute to managing adverse events and toxicity for patients undergoing metastatic colorectal cancer (mCRC) treatment. They explore the factors influencing patient adherence to third-line therapies and ways pharmacists can improve patient education to enhance adherence to treatment regimens.

Video content above is prompted by the following:

  • In what ways do pharmacists contribute to managing adverse events and toxicity for patients undergoing mCRC treatment?
  • What factors influence patient adherence to third-line therapies for mCRC, and how can pharmacists improve patient education to address these challenges and ensure better adherence to treatment regimens?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
1 expert in this video
4 experts in this video
4 experts in this video
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo